Abstract:BackgroundHepatocellular carcinoma (HCC) is the most common malignant tumor of the liver. Non-alcoholic fatty liver disease (NAFLD) is a frequent chronic liver disorder in developed countries. NAFLD can progress through the more severe non alcoholic steatohepatitis (NASH), cirrhosis and, lastly, HCC. Genetic and epigenetic alterations of coding genes as well as deregulation of microRNAs (miRNAs) activity play a role in HCC development. In this study, the C57BL/6J mouse model was long term high-fat (HF) or low-fat (LF) diet fed, in order to analyze molecular mechanisms responsible for the hepatic damage progression.MethodsMice were HF or LF diet fed for different time points, then plasma and hepatic tissues were collected. Histological and clinical chemistry assays were performed to assess the progression of liver disease. MicroRNAs’ differential expression was evaluated on pooled RNAs from tissues, and some miRNAs showing dysregulation were further analyzed at the individual level.ResultsCholesterol, low and high density lipoproteins, triglycerides and alanine aminotransferase increase was detected in HF mice. Gross anatomical examination revealed hepatomegaly in HF livers, and histological analysis highlighted different degrees and levels of steatosis, inflammatory infiltrate and fibrosis in HF and LF animals, demonstrating the progression from NAFLD through NASH. Macroscopic nodules, showing typical neoplastic features, were observed in 20 % of HF diet fed mice. Fifteen miRNAs differentially expressed in HF with respect to LF hepatic tissues during the progression of liver damage, and in tumors with respect to HF non tumor liver specimens were identified. Among them, miR-340-5p, miR-484, miR-574-3p, miR-720, whose expression was never described in NAFLD, NASH and HCC tissues, and miR-125a-5p and miR-182, which showed early and significant dysregulation in the sequential hepatic damage process.ConclusionsIn this study, fifteen microRNAs which were modulated in hepatic tissues and in tumors during the transition NAFLD-NASH-HCC are reported. Besides some already described, new and early dysregulated miRNAs were identified. Functional analyses are needed to validate the results here obtained, and to better define the role of these molecules in the progression of the hepatic disease.

Analysis of Non‑alcoholic Fatty Liver Disease Microrna Expression Spectra in Rat Liver Tissues.

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease.

Expressions of Key Regulatory Genes of the Lipid Metabolism in Livers During the Development of Rat Non-alcoholic Fatty Liver Disease

Identification of gene expression patterns in rat model of nonalcoholic fatty liver disease

Potential roles of miR-152 in nonalcoholic fatty liver disease by the bioinformatic analysis

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Differential Expression of Micrornas in Mouse Liver under Aberrant Energy Metabolic Status

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

A Study of the Changes of Hepatic Gene Expression in the Process of Nonalcoholic Fatty Liver Disease Development Using U230A Oligonucleotide Microarray

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Analysis of Pirna Expression Spectra in a Non-Alcoholic Fatty Liver Disease Mouse Model Induced by a Methionine- and Choline-Deficient Diet.

Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease

Roles of Micrornas in Immunopathogenesis of Non-Alcoholic Fatty Liver Disease Revealed by Integrated Analysis of Microrna and Mrna Expression Profiles

Effect Of Mir-34a In Regulating Steatosis By Targeting Ppar Alpha Expression In Nonalcoholic Fatty Liver Disease

MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes

Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-coenzyme a Hydratase Down-Regulation Exacerbates Hepatic Steatosis

MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice

Mir-149 Controls Non-Alcoholic Fatty Liver by Targeting Fgf-21

Identification and Study of Differentially Expressed Mirnas in Aged NAFLD Rats Based on High-Throughput Sequencing.